Cochlear Limited (CHEOF)
OTCMKTS · Delayed Price · Currency is USD
175.01
0.00 (0.00%)
At close: Dec 24, 2025
Cochlear Employees
Cochlear had 5,500 employees as of June 30, 2025. The number of employees increased by 205 or 3.87% compared to the previous year.
Employees
5,500
Change (1Y)
205
Growth (1Y)
3.87%
Revenue / Employee
$279,301
Profits / Employee
$46,357
Market Cap
11.50B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 5,500 | 205 | 3.87% |
| Jun 30, 2024 | 5,295 | 374 | 7.60% |
| Jun 30, 2023 | 4,921 | 421 | 9.36% |
| Jun 30, 2022 | 4,500 | 500 | 12.50% |
| Jun 30, 2021 | 4,000 | 0 | - |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| American Oncology Network | 1,914 |
| Glass House Brands | 374 |
| Silence Therapeutics | 116 |
| Elite Pharmaceuticals | 68 |
| Northwest Biotherapeutics | 25 |
| CytoDyn | 13 |
| OpGen | 1 |
Cochlear News
- 18 days ago - MRI 3T Cochlear Implant Market Poised for 9.96% CAGR Growth, North America Leads - GlobeNewsWire
- 23 days ago - Saluda Medical shares sink in worst ASX debut in decades - The Australian Financial Review
- 24 days ago - MED-EL Cochlear Implant Becomes First FDA-Approved Option for Children Seven Months and Older - Business Wire
- 25 days ago - Saluda Medical set for $775m ASX debut - The Australian Financial Review
- 2 months ago - Brokers throw open $125m Epiminder IPO book; Cochlear in for $10m - The Australian Financial Review
- 4 months ago - Cochlear reports FY results - Seeking Alpha
- 4 months ago - Cochlear Ltd (CHEOF) (FY25) Earnings Call Highlights: Navigating Growth and Challenges - GuruFocus
- 4 months ago - Cochlear CEO depends on built-up inventory as some export licenses lag - CNBC